|
Fiscal Period: November
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
Capitalization1 |
17 799 | 21 037 | 29 132 | 39 621 | 34 064 | - |
Entreprise Value (EV)1 |
21 858 | 26 596 | 34 146 | 39 621 | 38 006 | 37 464 |
P/E ratio |
44,6x | 40,1x | 59,1x | 45,8x | 44,7x | 37,3x |
Yield |
- | - | - | 0,79% | 0,86% | 0,97% |
Capitalization / Revenue |
4,94x | 5,25x | 6,60x | 9,24x | 7,44x | 6,99x |
EV / Revenue |
6,07x | 6,63x | 7,73x | 9,24x | 8,30x | 7,68x |
EV / EBITDA |
15,7x | 17,0x | 19,2x | 21,6x | 19,1x | 17,3x |
Price to Book |
2,32x | 2,71x | 3,53x | 4,01x | 3,77x | 3,56x |
Nbr of stocks (in thousands) |
398 893 | 394 165 | 400 988 | 398 359 | 398 359 | - |
Reference price (USD) |
44,6 | 53,4 | 72,7 | 99,5 | 85,5 | 85,5 |
Last update |
01/16/2018 | 01/15/2019 | 01/14/2020 | 01/13/2021 | 01/15/2021 | 01/15/2021 |
1 USD in Million Estimates
|
|
Income Statement Evolution | |
|
|
Annual Income Statement Data |
|
Fiscal Period: November
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
Net sales1 |
3 600 | 4 009 | 4 415 | 4 288 | 4 581 | 4 875 |
EBITDA1 |
1 390 | 1 565 | 1 779 | 1 837 | 1 994 | 2 166 |
Operating profit (EBIT)1 |
524 | 647 | 1 004 | 1 151 | 1 119 | 1 311 |
Operating Margin |
14,6% | 16,1% | 22,7% | 26,8% | 24,4% | 26,9% |
Pre-Tax Profit (EBT)1 |
372 | 424 | 743 | 883 | 903 | 1 081 |
Net income1 |
417 | 542 | 503 | 871 | 761 | 902 |
Net margin |
11,6% | 13,5% | 11,4% | 20,3% | 16,6% | 18,5% |
EPS2 |
1,00 | 1,33 | 1,23 | 2,17 | 1,91 | 2,29 |
Dividend per Share2 |
- | - | - | 0,68 | 0,74 | 0,83 |
Last update |
01/16/2018 | 01/15/2019 | 01/14/2020 | 01/13/2021 | 01/15/2021 | 01/14/2021 |
1 USD in Million 2 USD Estimates
|
|
|
Fiscal Period: November
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
Net Debt1 |
4 060 | 5 559 | 5 014 | 4 716 | 3 942 | 3 401 |
Net Cash position1 |
- | - | - | - | - | - |
Leverage (Debt / EBITDA) |
2,92x | 3,55x | 2,82x | 2,57x | 1,98x | 1,57x |
Free Cash Flow1 |
701 | 1 067 | 973 | 940 | 1 295 | 1 413 |
ROE (Net Profit / Equities) |
5,18% | 6,77% | 6,12% | 9,86% | 8,71% | 10,2% |
Shareholders' equity1 |
8 044 | 8 012 | 8 218 | 8 798 | 8 742 | 8 818 |
ROA (Net Profit / Asset) |
2,93% | 3,54% | 3,13% | 5,43% | 5,42% | 6,35% |
Assets1 |
14 246 | 15 308 | 16 075 | 15 983 | 14 057 | 14 207 |
Book Value Per Share2 |
19,2 | 19,7 | 20,6 | 21,3 | 22,7 | 24,0 |
Cash Flow per Share2 |
2,31 | 3,17 | 3,06 | 2,99 | 3,54 | 3,93 |
Capex1 |
260 | 223 | 278 | 275 | 279 | 293 |
Capex / Sales |
7,23% | 5,55% | 6,30% | 6,41% | 6,09% | 6,02% |
Last update |
01/16/2018 | 01/15/2019 | 01/14/2020 | 01/13/2021 | 01/15/2021 | 01/15/2021 |
1 USD in Million 2 USD Estimates
|
|
|
| Financial data source © 2021 S&P Global Market Intelligence
|
|
|
Exclusive: LSE to win EU approval for $27 billion Refinitiv deal - sources |
Capitalization (USD) 34 063 640 978 Net sales (USD) 4 414 600 000 Number of employees 15 500 Sales / Employee (USD) 284 813 Free-Float capitalization (USD) 27 963 443 055 Avg. Exchange 20 sessions (USD) 352 643 967 Average Daily Capital Traded 1,04%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Evolution Valeur d'Entreprise / EBITDA
|